Retinoic acid expression associates with enhanced IL-22 production by gamma delta T cells and innate lymphoid cells and attenuation of intestinal inflammation
Details
Publication Year 2013-06-03,Volume 210,Issue #6,Page 1117-1124
Journal Title
JOURNAL OF EXPERIMENTAL MEDICINE
Publication Type
Journal Article
Abstract
Retinoic acid (RA), a vitamin A metabolite, modulates mucosal T helper cell responses. Here we examined the role of RA in regulating IL-22 production by gamma delta T cells and innate lymphoid cells in intestinal inflammation. RA significantly enhanced IL-22 production by gamma delta T cells stimulated in vitro with IL-1 beta or IL-18 and IL-23. In vivo RA attenuated colon inflammation induced by dextran sodium sulfate treatment or Citrobacter rodentium infection. This was associated with a significant increase in IL-22 secretion by gamma delta T cells and innate lymphoid cells. In addition, RA treatment enhanced production of the IL-22-responsive antimicrobial peptides Reg3 beta and Reg3 gamma in the colon. The attenuating effects of RA on colitis were reversed by treatment with an anti-IL-22 neutralizing antibody, demonstrating that RA mediates protection by enhancing IL-22 production. To define the molecular events involved, we used chromatin immunoprecipitation assays and found that RA promoted binding of RA receptor to the IL-22 promoter in gamma delta T cells. Our findings provide novel insights into the molecular events controlling IL-22 transcription and suggest that one key outcome of RA signaling may be to shape early intestinal immune responses by promoting IL-22 synthesis by gamma delta T cells and innate lymphoid cells.
Publisher
ROCKEFELLER UNIV PRESS
Keywords
DENDRITIC CELLS; BOWEL-DISEASE; IMMUNITY; INTERLEUKIN-22; GENERATION; PROTECTION; MECHANISM; RESPONSES
Research Division(s)
Molecular Immunology
Open Access at Publisher's Site
http://jem.rupress.org/content/210/6/1117.long
Terms of Use/Rights Notice
This article is distributed under the terms of an Attribution–Noncommercial–Share Alike–No Mirror Sites license for the first six months after the publication date (see http://www.rupress.org/terms). After six months it is available under a Creative Commons License (Attribution–Noncommercial–Share Alike 3.0 Unported license, as described at http://creativecommons.org/licenses/by-nc-sa/3.0/).


Creation Date: 2013-06-03 12:00:00
An error has occurred. This application may no longer respond until reloaded. Reload 🗙